SCHEMBL3757039

SCHEMBL3757039

Cc1nc2ccccc2n1CCN1CCCCC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.74
USP2 O75604 2/20 0.58
TSHR P16473 2/20 0.58
ALOX15 P16050 2/20 0.58
P2RX7 Q99572 1/20 0.56
NPSR1 Q6W5P4 3/20 0.55
MAPT P10636 2/20 0.55
POLB P06746 1/20 0.55
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
MAPK1 P28482 3/20 0.55
OPRM1 P35372 3/20 0.55
OPRD1 P41143 3/20 0.55
OPRK1 P41145 2/20 0.55
TP53 P04637 2/20 0.55
KDM4E B2RXH2 1/20 0.55
RAB9A P51151 1/20 0.55
PKM P14618 3/20 0.54
ALDH1A1 P00352 2/20 0.54
GAA P10253 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6446137 0.85 LMNA (0.69) LMNATSHRP2RX7MAPTTP53
SCHEMBL3761561 0.82 CXCR4 (0.64) LMNAUSP2TSHRALOX15NPSR1
Hydrochloric Acid SCHEMBL8021990 0.81 P2RX7 (0.58) LMNAUSP2TSHRALOX15P2RX7
SCHEMBL18731438 0.81 LMNA (0.53) LMNAUSP2TSHRP2RX7MAPT
SCHEMBL3400537 0.80 CXCR4 (0.66) LMNAUSP2TSHRALOX15NPSR1
SCHEMBL18732121 0.78 LMNA (0.51) LMNAALOX15P2RX7NPSR1MAPT
SCHEMBL10219927 0.78 TLR9 (0.53) LMNAUSP2TSHRNPSR1MAPK1
SCHEMBL5547083 0.77 KMT2A (0.56) LMNAUSP2TSHRALOX15NPSR1
SCHEMBL2330274 0.77 LMNA (0.69) LMNATSHRP2RX7TP53RAB9A
SCHEMBL229041 0.77 POLB (0.67) LMNATSHRALOX15NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents GIVAUDAN S.A. (CH) 2010-11-25 US claimed
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents GIVAUDAN S.A. (CH) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents OR10J3, H1-3, ORC3 LMNA 1041/4885USP2 3760/4885TSHR 1643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.